Cambridge Investment Research Advisors’s Vident US Equity Strategy ETF VUSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-12,105
Closed -$567K 3313
2023
Q3
$567K Sell
12,105
-680
-5% -$32.6K ﹤0.01% 1986
2023
Q2
$611K Buy
+12,785
New +$577K ﹤0.01% 1980
2020
Q1
Sell
-7,107
Closed -$236K 2491
2019
Q4
$236K Buy
7,107
+54
+0.8% +$1.74K ﹤0.01% 2095
2019
Q3
$218K Buy
7,053
+6
+0.1% +$184 ﹤0.01% 2059
2019
Q2
$221K Buy
7,047
+30
+0.4% +$936 ﹤0.01% 1945
2019
Q1
$217K Buy
+7,017
New +$215K ﹤0.01% 2017
2018
Q4
Sell
-6,933
Closed -$239K 2290
2018
Q3
$239K Buy
+6,933
New +$240K ﹤0.01% 1941

Other funds holding VUSE

Cambridge Investment Research Advisors's VUSE Position: Q4 2023 in Review

Cambridge Investment Research Advisors sold out of Vident US Equity Strategy ETF (VUSE) in Q4 2023, closing a stake of 12,105 shares — an estimated $567K sold.

Cambridge Investment Research Advisors first reported a position in VUSE in Q3 2018 and held it in 7 quarters. The position peaked at $611K in Q2 2023. 24 funds tracked by Wall St. Rank hold VUSE as of Q4 2023.

  • Cambridge Investment Research Advisors reported no remaining Vident US Equity Strategy ETF position as of Q4 2023 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 12,105 Vident US Equity Strategy ETF shares in Q4 2023, an estimated $567K.
  • Cambridge Investment Research Advisors first reported a position in Vident US Equity Strategy ETF in Q3 2018 and held it in 7 quarters.
  • Cambridge Investment Research Advisors's Vident US Equity Strategy ETF position peaked at $611K in Q2 2023.
  • 24 funds tracked by Wall St. Rank held Vident US Equity Strategy ETF as of Q4 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.